Catalyst Funds Management’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
WDC
BL
CM
FLPIM
GRP
Catalyst Funds Management's GNLX Position: Q2 2026 in Review
Catalyst Funds Management sold out of Genelux (GNLX) in Q2 2026, closing a stake of 21,824 shares — an estimated $52.8K sold.
Catalyst Funds Management first reported a position in GNLX in Q2 2024 and held it in 4 quarters. The position peaked at $52.8K in Q1 2026. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.
- Catalyst Funds Management reported no remaining Genelux position as of Q2 2026 after selling out during the quarter.
- Catalyst Funds Management sold 21,824 Genelux shares in Q2 2026, an estimated $52.8K.
- Catalyst Funds Management first reported a position in Genelux in Q2 2024 and held it in 4 quarters.
- Catalyst Funds Management's Genelux position peaked at $52.8K in Q1 2026.
- 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.
Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.